A meta-analysis of the association between calprotectin and the severity of COVID-19
- 21 January 2022
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 84 (3) , e31-e33
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patientsJournal of Infection, 2021
- Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptomsScientific Reports, 2021
- Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID‐19Journal of Clinical Laboratory Analysis, 2021
- Calprotectin and SARS-CoV-2: A Brief-Report of the Current LiteratureHealthcare, 2021
- Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19International Journal of Molecular Sciences, 2021
- Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patternsJournal of Internal Medicine, 2021
- Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational studyInflammation Research, 2021
- Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-AnalysisJournal of Clinical Medicine, 2021
- COVID-19 and intestinal inflammation: Role of fecal calprotectinDigestive and Liver Disease, 2020
- Faecal calprotectin indicates intestinal inflammation in COVID-19Gut, 2020